Pharma Journalist 9001 posts 0 comments

Teva Pharmaceuticals International GmbH has entered into a global licensing agreement with Polpharma Biologics International AG for exclusive commercialization rights to Polpharma…
Read More...

Samsung Bioepis Co., Ltd. has entered into a licensing agreement with Proteina Co., Ltd. to support the development of artificial intelligence-based antibody therapeutics under a…
Read More...

Evogene has partnered with Tel Aviv University’s Blavatnik Center for Drug Discovery to establish a joint initiative aimed at accelerating small-molecule drug discovery programmes…
Read More...

AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with transthyretin-mediated amyloid…
Read More...

OTR Therapeutics has entered into a strategic collaboration with LG Chem to identify, evaluate and develop novel oncology assets originating from China, as both companies seek to expand…
Read More...

Bayer has formed a strategic clinical trials alliance with the University of Colorado Anschutz, UCHealth and Children’s Hospital Colorado, marking the company’s first collaboration of…
Read More...

Certara, Inc. has announced a collaboration with NVIDIA aimed at expanding the use of agentic artificial intelligence across drug discovery and development workflows. The partnership…
Read More...

Cyllene Therapeutics has closed a €33 million Series C financing round to advance clinical development of its lead DNA medicine candidate, EG110A, for severe neurogenic bladder…
Read More...

Biocytogen and Whitehawk Therapeutics have entered into a global collaboration to develop bispecific antibody-drug conjugates, expanding efforts to apply dual-targeting antibody…
Read More...

Vanda Pharmaceuticals has received Rare Pediatric Disease Designation from the US Food and Drug Administration for VCA-894A, an investigational antisense oligonucleotide therapy being…
Read More...